ProCE Banner Activity

Medical Minute 2: Treatment and Management of Indolent Systemic Mastocytosis


This downloadable slide set presents an expert discussion detailing the limitations of conventional treatments for indolent systemic mastocytosis and the role of disease-modifying therapy in improving patient outcomes.

Released: November 10, 2023



Mariana Castells

Mariana Castells, MD, PhD

Director, Drug Hypersensitivity and Desensitization Center
Director, Mastocytosis Center
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from Blueprint Medicines.

Blueprint Medicines